Skip to Content
Merck
CN

03-0188-00

SMC® Human Phospho-α-Synuclein (S129) High Sensitivity Immunoassay Kit

Used for ultrasensitive quantification of Human Phospho-α-Synuclein (S129) in human serum, plasma, and cerebrospinal fluid (CSF)

Synonym(s):

p-α-synuclein S129 immunoassay kit, p-α-synuclein Ser129 immunoassay kit, p-α-synuclein Single Molecule Counting Kit, p-α-synuclein ultra-sensitive immunoassay

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

NACRES:
NA.84
UNSPSC Code:
12161503
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

SMC® Human Phospho-α-Synuclein (S129) High Sensitivity Immunoassay Kit, Used for ultrasensitive quantification of Human Phospho-α-Synuclein (S129) in human serum, plasma, and cerebrospinal fluid (CSF)

product line

SMC®

usage

 kit sufficient for 96 wells

species reactivity

human

manufacturer/tradename

SMC®

technique(s)

single molecule counting: suitable

input

cerebrospinal fluid (CSF)
serum
plasma (K2 EDTA)

UniProt accession no.

compatibility

for use with FemtoQuest and SMCxPRO® instruments

shipped in

wet ice

storage temp.

2-8°C

Packaging

96 well assay

Legal Information

SMC is a registered trademark of Singulex
SMCxPRO is a registered trademark of Merck KGaA, Darmstadt, Germany
FEMTOQUEST is a trademark of Merck KGaA, Darmstadt, Germany

Analysis Note

  • Sensitivity: LLOQ 100 fg/mL* (SMCxPRO® Instrument)
  • Standard Curve Range: 50-50,000 fg/mL
  • Intra-assay CV: <15%
  • Inter-assay CV: <20%
  • Linearity: Serum: 101% Plasma: 96% CSF: 99%
  • Recovery: Serum: 85% Plasma: 89% CSF: 100%
*Indicative LLOQ created from average of 14 independent in house runs, where >80% met same value defined with CV & Recovery +/- 20%. Refer to CoA for lot specific performance.
Neurological DisordersNeurodegenerative DiseasesSynucleinopathies

Application

Neurological DisordersNeurodegenerative DiseasesSynucleinopathies

Biochem/physiol Actions

Although Phospho-α-Synuclein (S129) was detectable in non-human primate (rhesus macaque and cynomolgus monkey), feline, rat, mouse, and canine samples, the assay has not been verified for these species.

Disclaimer

Our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Features and Benefits

  • Femtogram-Scale Analysis: Achieves ultra-low detection limits (fg/mL) in serum, plasma or CSF.
  • Advanced Signal Optimization: Incorporates expanded dynamic range with reduced background noise, ensuring reproducibility.
  • Seamless Workflow: Combines a familiar sandwich immunoassay architecture with next-generation sensitivity.
  • Automation Compatibility: Supports robotic liquid handling integration to reduce touch time and improve efficiency.
  • Technical Expertise: Supported by skilled field scientists and technical teams with SMC® expertise.

General description

Phospho-α-synuclein (S129) is a modified form of the protein α-synuclein, characterized by the phosphorylation at serine 129. This post-translational modification influences the protein′s structure and function, promoting its aggregation into toxic fibrils, which are a hallmark of several neurological disorders. In healthy neurons, α-synuclein plays a role in synaptic function, regulating neurotransmitter release and maintaining synaptic integrity. However, when phosphorylated at S129, α-synuclein tends to misfold and aggregate, leading to the formation of Lewy bodies, which are implicated in neurodegenerative diseases such as Parkinson′s disease and dementia with Lewy bodies.

Phospho-α-synuclein (S129) also contributes to neuroinflammation by activating microglial cells, which can exacerbate neuronal damage and promote disease progression. Its presence in the brain serves as a biomarker for neurodegeneration, highlighting its critical role in the pathophysiology of various neurodegenerative conditions.

pictograms

Skull and crossbonesHealth hazard

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2 - Repr. 1B

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Regulatory Information

新产品
This item has

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Related Content

通过适合的免疫检测产品,探索神经免疫和神经炎症细胞因子及神经退行性疾病生物标志物。

在强大的SMCxPRO®检测平台上,采用单分子计数(SMC®)高灵敏度免疫检测试剂盒,准确可靠地检测健康和病患来源的主要神经学蛋白分析物,进行神经科学研究。分析各种神经科学生物标志物,如神经丝蛋白轻链(NF-L)、胶质纤维酸性蛋白(GFAP)、Tau蛋白、β-淀粉样蛋白等。

Discover how to expand neuroscience biomarker research with high sensitivity immunoassays, such as Single Molecule Counting (SMC®) assays. These assays give researchers the tools they need to detect low-abundant blood-based biomarkers and expand biomarker options in neuroscience research.

Explore high-sensitivity SMC® neurology immunoassays that precisely measure low levels of neurology protein analytes, such as NF-L or Tau proteins.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service